Skip to main content
Completed Clinical Trials

Inhaled Doxorubicin in Treating Patients With Advanced Solid Tumors Affecting the Lungs

By April 24, 2017No Comments

Condition

Lung Cancer|Malignant Mesothelioma|Metastatic Cancer

Estimated Enrollment: null

Age Group: 18 Years and older   (Adult, Senior)

Gender: All

Study Type: Interventional

Study Design Allocation: Primary Purpose: Treatment

Study ID Numbers: 000088|00-C-0088|CDR0000067718

Study First Received: July 11, 2001

Last Updated: March 14, 2012

Estimated Primary Completion Date: null

 

Primary Outcome Measures:

Sponsors and Collaborators:

National Institutes of Health Clinical Center (CC)|National Cancer Institute (NCI)

Website Link: https://ClinicalTrials.gov/show/NCT00020124

Leave a Reply